Andy, Author at BioHealth Innovation

News

January 27, 2025

MedStar Health First in Maryland to Implant FDA Approved Tricuspid Valves in Patients Without Need for Open Heart Surgery

BALTIMORE, Jan. 24, 2025 /PRNewswire/ -- In two separate procedures, MedStar Health cardiac experts at MedStar Union Memorial Hospital reached new heights…

Andy

Love0

News

January 27, 2025

Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 AURORA Trial of Descartes-08 in Myasthenia Gravis

FREDERICK, Md., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering…

Andy

Love0

News

January 27, 2025

AI and Health Innovation: Leading the Future of Tech and Collaboration with UMD Dean Amitabh Varshney on BioTalk

In this episode of BioTalk, host Rich Bendis is joined by Amitabh Varshney, Dean of the College of Computer, Mathematical,…

Andy

Love0

BioTalk with Rich Bendis Podcast

January 27, 2025

AI and Health Innovation: Leading the Future of Tech and Collaboration with UMD Dean Amitabh Varshney on BioTalk

In this episode of BioTalk, host Rich Bendis is joined by Amitabh Varshney, Dean of the College of Computer, Mathematical,…

Andy

Love0

News

January 25, 2025

TEDCO Announces Inaugural Maryland Student Venture Showcase and Pava LaPere Innovation Awards Recipients

COLUMBIA, Md., Jan. 24, 2025 /PRNewswire/ -- TEDCO, Maryland's economic engine for technology companies, announced nine awardees for the inaugural Maryland Student Venture Showcase and…

Andy

Love0

News

January 24, 2025

BHI Reflections from the 43rd Annual J.P. Morgan Healthcare Conference

The 43rd Annual J.P. Morgan Healthcare Conference, held from January 13–16, 2025, in San Francisco, once again brought together industry…

Andy

Love0

News

January 24, 2025

Pharmaceutical Technology: Emergent seeking to reverse fortunes and become a major overdose treatment player

Emergent BioSolutions (Gaithersburg, US) has purchased US and Canadian rights to Kloxxado, adding to its opioid overdose treatment portfolio, which…

Andy

Love0

News

January 24, 2025

TEDCO Invests in Nostopharma

COLUMBIA, Md., (January 24, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $250,000 Builder Fund investment…

Andy

Love0

News

January 24, 2025

Ascentage Pharma Announces Pricing of U.S. Initial Public Offering

ROCKVILLE, Md. and SUZHOU, China, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the…

Andy

Love0

News

January 23, 2025

IonQ CEO on Timeline to Quantum Value

COLLEGE PARK, Md.--(BUSINESS WIRE)-- The following is a statement from Peter Chapman, Chairman and CEO of IonQ (NYSE: IONQ): Today’s classical…

Andy

Love0

Andy

MedStar Health First in Maryland to Implant FDA Approved Tricuspid Valves in Patients Without Need for Open Heart Surgery

Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 AURORA Trial of Descartes-08 in Myasthenia Gravis

AI and Health Innovation: Leading the Future of Tech and Collaboration with UMD Dean Amitabh Varshney on BioTalk

AI and Health Innovation: Leading the Future of Tech and Collaboration with UMD Dean Amitabh Varshney on BioTalk

TEDCO Announces Inaugural Maryland Student Venture Showcase and Pava LaPere Innovation Awards Recipients

BHI Reflections from the 43rd Annual J.P. Morgan Healthcare Conference

Pharmaceutical Technology: Emergent seeking to reverse fortunes and become a major overdose treatment player

TEDCO Invests in Nostopharma

Ascentage Pharma Announces Pricing of U.S. Initial Public Offering

IonQ CEO on Timeline to Quantum Value

About BioHealth Innovation

Contact

Connect

Andy

About BioHealth Innovation

Contact

Connect

Search